Immune microenvironment in high-grade serous ovarian carcinomas: association with molecular profiles and neoadjuvant therapy outcome. (2023). Voprosy Onkologii, 69(1), 74-81. https://doi.org/10.37469/0507-3758-2023-69-1-74-81